Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

Essential Fatty Acid Deficiency clinical trials

1 of 1 indexed Essential Fatty Acid Deficiency trials are currently recruiting.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Essential Fatty Acid Deficiency: 1 US clinical trial tracked, 1 recruiting.

Essential Fatty Acid Deficiency is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Fresenius Kabi, running 1 of these trials.

Enrollment posture brief

Registry condition essential-fatty-acid-deficiency

OPEN 1 | RECR 100% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Essential Fatty Acid Def (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Essential Fatty Acid Deficiency

Essential Fatty Acid Deficiency lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Essential Fatty Acid Deficiency on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Essential Fatty Acid Deficiency is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Fresenius Kabi 1 trials

Named interventions

Most-linked intervention names on Essential Fatty Acid Deficiency records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Omegaven® (fish oil triglycerides) Injectable Emulsion Drug
1 trials

US sites by state

Facility locations filed on Essential Fatty Acid Deficiency trials. A trial with sites in several states counts in each.

Washington 1 trials
Texas 1 trials
Tennessee 1 trials
Oklahoma 1 trials
Ohio 1 trials
Massachusetts 1 trials
Illinois 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Essential Fatty Acid Deficiency page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Essential Fatty Acid Deficiency trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Fresenius Kabi sponsors the most Essential Fatty Acid Deficiency trials on record, review their full trial history before evaluating a specific study. See Fresenius Kabi's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Essential Fatty Acid Deficiency condition card totals 1 registered trials; most-linked intervention Omegaven® (fish oil triglycerides) Injectable Emulsion; top US site state Washington. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.